Mydecine Innovations Group Inc (MYCOF)
0.0076
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Mydecine Innovations Group Net Income (Quarterly): -8.548M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -8.548M |
| June 30, 2023 | -2.365M |
| March 31, 2023 | -5.657M |
| December 31, 2022 | 0.3326M |
| September 30, 2022 | -0.906M |
| June 30, 2022 | -2.045M |
| March 31, 2022 | -4.449M |
| December 31, 2021 | -8.633M |
| September 30, 2021 | -3.602M |
| June 30, 2021 | -6.777M |
| March 31, 2021 | -4.068M |
| December 31, 2020 | -9.084M |
| September 30, 2020 | -8.551M |
| June 30, 2020 | -3.284M |
| March 31, 2020 | -0.1435M |
| December 31, 2019 | -14.15M |
| September 30, 2019 | -0.6363M |
| June 30, 2019 | -0.2733M |
| March 31, 2019 | -1.163M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.573M |
| September 30, 2018 | -1.090M |
| June 30, 2018 | -4.527M |
| March 31, 2018 | -3.174M |
| December 31, 2017 | -8.197M |
| September 30, 2017 | -0.2848M |
| June 30, 2017 | -2.466M |
| March 31, 2017 | -2.609M |
| December 31, 2016 | -4.901M |
| September 30, 2016 | -0.3018M |
| June 30, 2016 | -0.3796M |
| March 31, 2016 | -0.1317M |
| December 31, 2015 | -0.8412M |
| September 30, 2015 | -0.2107M |
| June 30, 2015 | -1.947M |
| March 31, 2015 | -0.6843M |
| December 31, 2014 | -0.3389M |
| September 30, 2014 | -0.6242M |
| May 31, 2014 | -0.0045M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-14.15M
Minimum
Dec 2019
0.3326M
Maximum
Dec 2022
-4.602M
Average
-3.835M
Median
Net Income (Quarterly) Benchmarks
| Rimrock Gold Corp | -0.0749M |
| InMed Pharmaceuticals Inc | -1.723M |
| Venus Concept Inc | -9.794M |
| Juva Life Inc | -1.466M |
| Lucy Scientific Discovery Inc | -2.620M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.270M |
| EPS Diluted (Quarterly) | -1.170 |
| Enterprise Value | 4.438M |
| Earnings Yield | -20.25K% |
| Normalized Earnings Yield | -54619.84 |